31 active
/
60 total (since 2015)
5
Phase 1 Active
10 total
11
Phase 2 Active
20 total
10
Phase 3 Active
18 total
9
Phase 4 Active
19 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Cardurion Pharmaceuticals, Inc. 1 0 1
Solid Biosciences Inc. 1 0 0
Agiana Pharmaceuticals 1 0 0
AskBio Inc 1 0 0
NCT07174986 RECRUITING
Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest
Gabriel Riva n=916
NCT06835491 RECRUITING
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
Versailles Hospital n=674
NCT06281977 RECRUITING
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Ottawa Heart Institute Research Corporation n=192
NCT05047198 RECRUITING
Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Ottawa Heart Institute Research Corporation n=244
NCT06965998 RECRUITING
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
Ottawa Hospital Research Institute n=50
NCT05631730 RECRUITING
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
Oslo University Hospital n=50
NCT04952610 ENROLLING BY INVITATION
Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
Milestone Pharmaceuticals Inc. n=130
NCT05890664 RECRUITING
Colchicine After Electrocardioversion for Atrial Fibrillation
University Hospital, Basel, Switzerland n=416
NCT06717685 RECRUITING
Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Rashid Latif Medical College n=210
NCT05213104 ACTIVE NOT RECRUITING
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
Assistance Publique - Hôpitaux de Paris n=186
NCT04134845 COMPLETED
A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.
Vanderbilt University Medical Center n=68
NCT05410860 COMPLETED
Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia
Corxel Pharmaceuticals n=500
NCT04053816 COMPLETED
Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter
Barts & The London NHS Trust n=1,684
NCT03635996 TERMINATED
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
Milestone Pharmaceuticals Inc. n=169
NCT03464019 TERMINATED
Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
Milestone Pharmaceuticals Inc. n=1,097
NCT04072835 COMPLETED
Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Milestone Pharmaceuticals Inc. n=1,116
NCT02624765 COMPLETED
Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)
Edgar Jaeggi n=105
NCT04392362 COMPLETED
A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
University of Pretoria n=30
Data: ClinicalTrials.gov